LIVN שולי רווח נקי ממכירות LivaNova PLC

לוגו גרפי של LivaNova Group (LIVN)

LivaNova PLC (LIVN) faces risks associated with potential litigation and product recalls. The company's pricing policy is inconsistent: neurostimulators generate high profits, whereas circulation devices depend on government budgets. Own manufacturing facilities in Europe and the US guarantee supply stability. Net sales margins help identify profit compression in a timely manner, and 13.00 indicates the current level of this metric.

LivaNova Corp (LIVN) - רווחיות מכירות נקייה מ-04.07.2022 עד 19.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת LivaNova Group (LIVN)

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח ראשוני של החברה:LivaNova PLC
סחורת הדגל של LivaNova plc

LivaNova PLC (LIVN) high-tech ecosystem in neuromodulation and cardiac surgery creates barriers to entry for competitors, which should translate into a steady stream of profits. An analysis of aggregate net profit margins allows for an assessment of the net income share of revenue, separating fundamental business efficiency from random fluctuations and identifying hidden operational flaws that could lead to overpaying for the asset.